Shang Hai Zheng Quan Bao·2025-11-04 19:55Group 1: Medical Device Registration - The company announced that its subsidiary, Shanghai Wanzijian Biotechnology Co., Ltd., and Healgen Scientific LLC have recently obtained medical device registration certificates in China, Australia, and Singapore [1] - The registration of these products enhances the variety of the company's flow cytometry technology platform and expands the market for respiratory triple detection products internationally [1] Group 2: Board of Directors Changes - The company reported the resignation of independent director Li Bo due to personal work reasons and has proposed Chen Junze as a candidate for the independent director position [4][5] - Chen Junze's qualifications and independence have been verified and will be submitted for shareholder approval [5][6] Group 3: Shareholder Meeting Notification - The company will hold its second extraordinary general meeting of 2025 on November 20, 2025, with both on-site and online voting options available [7][9] - The meeting will discuss various proposals that have been approved by the board and disclosed in previous announcements [12]